Patient Safety: An Injectable Education


Until recently, the effects of all injectable filling agents were temporary and very rarely associated with permanent problems. In the past, the permanent injectable silicone had been used but had been so problematic that the Justice Department filed injunctions against certain physicians on behalf of the FDA. After 2000 a dangerous pattern grew in the corridors of Washington DC, where politics and money changed the face of America and the field of aesthetics to the detriment of the faces of the consumers. Industry has accomplished the approval of synthetic agents that should have never reached the market. Once injected under skin, the body cannot digest these agents and the immune system walls them off with resultant formation of nodules, which at times require surgical removal.

Share and Cite:

A. Klein, "Patient Safety: An Injectable Education," Journal of Cosmetics, Dermatological Sciences and Applications, Vol. 3 No. 3B, 2013, pp. 36-39. doi: 10.4236/jcdsa.2013.33A2009.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Doctors Warning Facial Fillers.
[2] A. W. Klein, “Avoiding Adverse Events with Fillers: Fat, Collagen, Radiance, Silicone, Restylane, Artecoll: Letter to the Editor,” Cosmetic Surgery Times, Vol. 6, No. 6, 2003, p. 3.
[3] A. W. Klein, “Reluctant to Use Artecoll: Letter to the Editor,” Skin & Allergy News, Rockville, 2002, p. 16.
[4] B. Azizzadeh and M. Graivier, “Injectable Poly-L-Lactic Acid (Sculptra): Technical Considerations in Soft-Tissue Contouring,” Plastic and Reconstructive Surgery, Vol. 118, Suppl. 3, 2006, pp. 55S-63S.
[5] A. W. Klein, “The Whole Truth Please—Sculptra Review —RealSelf,” 2009. review/the-whole-truth-please
[6] A. W. Klein, “Soft Tissue Augmentation 2006: Filler Fantasy,” Dermatologic Therapy, Vol. 19, No. 3, 2006, pp. 129-133.
[7] R. Rundle, “Things Get Ugly over a Beauty Injection-WSJ.” SB118834446251311594
[8] J. Alijotas-Reig, V. Garcia-Gimenez and M. Vilardell-Tarres, “Late-Onset Immune-Mediated Adverse Effects after Poly-L-Lactic Acid Injection in Non-HIV Patients: Clinical Findings and Long-Term Follow-Up,” Dermatology, Vol. 219, No. 4, 2009, pp. 303-308.
[9] A. W. Klein, “Sculptra: An Injectable Disaster.”
[10] C. M. Burgess and R. M. Quiroga, “Assessment of the Safety and Efficacy of Poly-L-Lactic Acid for the Treatment of HIV-Associated Facial Lipoatrophy,” Journal of the American Academy of Dermatology, Vol. 52, No. 2, 2005, pp. 233-239.
[11] A. Klein, “Filler Follies, Huffington Post,” 2010. filler-follies_b_410987.html
[12] Apr 23, 2012—Dear Dr. Klein Disaster: I Was Injected Sculptra First Time in May 2009 (3 Series) in Cheek Hollows, Temples and Neck. I Had Excelent Subtle Results, ...What Do About Sculptra (NewFill) Lumps and Granulomas Doctor...
[13] A. W. Klein, “What Do about Sculptra (NewFill) Lumps and Granulomas.” question/what-can-do-about-sculptra-lumps
[14] A. W. Klein, “Substances for Soft Tissue Augmentation,” In: I. Freedberg, Ed., Fitzpatrick’s Dermatology in General Medicine, 6th Edition, McGraw Hill, New York, 2003.
[15] A. W. Klein and B. W. Ayers, “Lip Augmentation,” In: S. J. Aston, Ed., Aesthetic Plastic Surgery, Elsevier BV, Amsterdam, 2009, pp. 855-860.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.